Literature DB >> 24222673

Putting GlaxoSmithKline to the test over paroxetine.

Peter Doshi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24222673     DOI： 10.1136/bmj.f6754

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  Will clinical trial data disclosure reduce incentives to develop new uses of drugs?

Authors:  W Nicholson Price; Timo Minssen
Journal:  Nat Biotechnol       Date:  2015-07       Impact factor: 54.908

2.  Government regulators must steward drug transparency.

Authors:  Matthew Herder
Journal:  Nat Med       Date:  2014-08       Impact factor: 53.440

3.  Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence.

Authors:  Joanna Le Noury; John M Nardo; David Healy; Jon Jureidini; Melissa Raven; Catalin Tufanaru; Elia Abi-Jaoude
Journal:  BMJ       Date:  2015-09-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.